Arcturus Therapeutics Holdings, Inc. (ARCT)
13.75
+0.88
(+6.84%)
USD |
NASDAQ |
Oct 09, 15:07
Arcturus Therapeutics Holdings Net Income (Quarterly) : -23.78M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.78M |
| March 31, 2026 | -26.96M |
| December 31, 2025 | -29.08M |
| September 30, 2025 | -13.45M |
| June 30, 2025 | -9.18M |
| March 31, 2025 | -14.08M |
| December 31, 2024 | -30.00M |
| September 30, 2024 | -6.903M |
| June 30, 2024 | -17.22M |
| March 31, 2024 | -26.82M |
| December 31, 2023 | -8.573M |
| September 30, 2023 | -16.22M |
| June 30, 2023 | -52.55M |
| March 31, 2023 | 50.75M |
| December 31, 2022 | 117.35M |
| September 30, 2022 | -35.27M |
| June 30, 2022 | -21.56M |
| March 31, 2022 | -51.17M |
| December 31, 2021 | -38.66M |
| September 30, 2021 | -54.08M |
| June 30, 2021 | -54.58M |
| March 31, 2021 | -56.35M |
| December 31, 2020 | -31.10M |
| September 30, 2020 | -21.00M |
| June 30, 2020 | -10.26M |
| Date | Value |
|---|---|
| March 31, 2020 | -9.777M |
| December 31, 2019 | -10.99M |
| September 30, 2019 | -7.433M |
| June 30, 2019 | -0.685M |
| March 31, 2019 | -6.884M |
| December 31, 2018 | -1.011M |
| September 30, 2018 | -4.253M |
| June 30, 2018 | -9.95M |
| March 31, 2018 | -6.571M |
| December 31, 2017 | -1.136M |
| September 30, 2017 | -2.555M |
| June 30, 2017 | -3.691M |
| March 31, 2017 | -3.52M |
| December 31, 2016 | -5.927M |
| September 30, 2016 | -7.802M |
| June 30, 2016 | -5.788M |
| March 31, 2016 | -5.086M |
| December 31, 2015 | -4.887M |
| September 30, 2015 | -4.262M |
| June 30, 2015 | -5.123M |
| March 31, 2015 | -5.177M |
| December 31, 2014 | -6.802M |
| September 30, 2014 | -10.49M |
| June 30, 2014 | -7.78M |
| March 31, 2014 | -7.766M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Exelixis, Inc. | 212.05M |
| Ionis Pharmaceuticals, Inc. | -114.65M |
| United Therapeutics Corp. | 333.00M |
| PTC Therapeutics, Inc. | 83.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.88M |
| Total Expenses (Quarterly) | 24.66M |
| EPS Diluted (Quarterly) | -0.8368 |
| Enterprise Value | 197.25M |
| Gross Profit Margin (Quarterly) | 31.82% |
| Profit Margin (Quarterly) | -2.70K% |
| Earnings Yield | -24.11% |
| Normalized Earnings Yield | -22.73 |